---

Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡

---

Roche

🌎 roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics, founded in 1896 in Basel, Switzerland. The company focuses on advancing science to improve people's lives, with a strong emphasis on personalized healthcare. Roche is the world's largest biotech company, known for its innovative medicines in oncology, immunology, infectious diseases, and diagnostics. The company aims to improve patient access to medical innovations and has been recognized for its sustainability efforts in the pharmaceuticals and biotechnology industry.

---

Roche - Latest News and Updates

• Roche has adapted its open-source clinical trial reporting tool Teal into Teal4Real, allowing biomedical professionals to perform straightforward data analysis directly.
• Roche is currently hiring for the position of Chief of Staff in Japan.
• Roche partnered with Yemaachi Biotech to launch The African Cancer Atlas Consortium, creating a comprehensive cancer genomic database for African populations.
• Roche Canada announced Health Canada's authorization of Itovebi® (inavolisib) for treating PIK3CA-mutated, hormone receptor-positive, HER2-negative breast cancer, showing a 57% reduction in disease progression or death in the INAVO120 study.
• The US FDA cleared Roche's Elecsys test for preeclampsia on February 14, 2025.

• On February 12, 2025, the FDA approved Roche's Evrysdi (risdiplam) as the first and only tablet for treating spinal muscular atrophy, offering a non-invasive, disease-modifying option.
• Roche announced that NT-proBNP is now reimbursed under the MBS in 2025 to aid heart failure diagnosis outside hospitals.
• Roche is rumored to be planning a reverse merger with LumiraDx, similar to LumiraDx's previous merger with Covington Associates Healthcare.
• Roche's Elecsys sFlt-1/PlGF ratio test for preeclampsia has received FDA clearance, providing a tool to assess the risk of severe preeclampsia.
• Roche is currently hiring for the position of Head Technology and Data (PTDC-D) in Switzerland.

---

Sign up to receive regular updates

If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.